Andrew
Senior Member
- Messages
- 2,523
- Location
- Los Angeles, USA
I was searching Google but have to stop for now. Head spinning. I'm having trouble figuring out if we can actually get this stuff.
Any thoughts on the below:
Any thoughts on the below:
TREATMENT WITH PERNA CANALICULUS AND D-GLUCAN OF CFS PATIENTS: RESTORATION OF NK ACTIVITY AND IMPROVEMENT OF CLINICAL SYMPTOMS - O. YUN, Y. OKUBO, K. TESHIGAWARA, A. UCHIDA
Radiation Biology Center, Kyoto University, Japan
Chronic fatigue syndrome (CFS) is characterized by persisting debilitating fatigue and neuropsychiatric abnormalities. No effective therapy has been established.
In the present study we investigated immunological functions in patients with CFS and evaluated the therapeutic efficacy of the New Zealand green-lipped mussel extract perinea canaliculus (seatone) and S-1,3-D-glucan of Basidiomycetes Schizophyllum commune Frie sizofiran.
Vast majority of CFS patients had depressed blood natural killer (NK) activity, especially against virus-infected targets, elevated serum interleukin 2 (IL-2) levels and increased spontaneous DNA synthesis of blood lymphocytes. While lysis of tumor targets by NK cells required protein tyrosine phosphorylation, NK-mediated lysis of virus-infected targets was independent on Ca influx. NK cells were not activated by IL-2, though they expressed normal levels of a and s-chain of IL-2 receptors, to, which IL-2 effectively bound. Stimulation with failed to transduce signals in NK cells of CFS patients. CFS patients received daily oral administration of perinea canaliculus or sizofiran.
After 4-8 weeks of the treatment the patients showed an improvement of NK activity, acquisition of IL-2 responsiveness, and normalization of spontaneous DNA synthesis of lymphocytes and serum IL-2 levels. Following these immunological improvement, approximately 80 % patients completely or partially recovered from debilitating fatigue, neuropsychologic complaints and other associated symptoms. There was a close association between the improvement of host immunity and clinical symptoms.
These results suggest that perinea canaliculus and sizofiran may be effective therapeutic agents for patients with CFS and suggest the involvement of NK cells in the clinical course of CFS.
http://www.ncf-net.org/conference/firstwoldabstracts.htm